Registry for older adults with blood cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create a registry for older patients aged 50 and above who have been diagnosed with hematologic malignancies. Participants will undergo a geriatric assessment questionnaire and objective physical function testing, including the Short Physical Performance Battery and muscle strength assessment. The study will track changes in patient-reported outcomes over time through follow-up assessments at 3 months, 6 months, and one year. Additionally, a blood or saliva sample will be collected to support future research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients are ≥50 years of age.
* Patients have a biopsy proven diagnosis of Hematologic Malignancy (Multiple Myeloma, AL Amyloidosis, Waldenstrom's Macrogloblunemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Myelodysplastic syndromes, Myeloproliferative Neoplasm, Acute/Chronic Myeloid Leukemia, Acute/Chronic Lymphoid Leukemia).
* Patients have appointments at UAB including if they are an inpatient or other clinic locations.

Exclusion Criteria:

* Individuals who are \<50 years old.
* Patients who do not read and/or speak English will not be eligible for this study as many of the questionnaires are not validated in other languages. No exclusions will be made based on gender, ethnicity or race.

Where it's running

• Kirklin Clinic of UAB Hospital
  Birmingham, Alabama, United States Recruiting

Study contacts

• Study coordinator: Landon Martin, BS
• Email: landoncmartin@uabmc.edu
• Phone: (205) 638-2120

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cohort of patients with plasma cell disorders at Peking University First Hospital

  This study is looking at hospitalized patients with plasma cell disorders to see how their treatment and disease status affect their outcomes over time.

  Recruiting Peking University First Hospital · Beijing · NCT05283993

• Registry for adults with plasma cell disorders

  This study is creating a registry for adults with plasma cell disorders like multiple myeloma to track their health and care experiences over time while also collecting blood samples for future research.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT03717844

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Go-slow isatuximab and dexamethasone with later lenalidomide for ultra-frail multiple myeloma patients

  This trial will try a gentle, phased start of isatuximab and dexamethasone, adding lenalidomide later, for newly diagnosed, ultra-frail adults with multiple myeloma or plasma cell leukemia to help them stay on treatment and feel better.

  Recruiting Phase 2 University of Utah · Chicago, Illinois and 1 other locations · NCT06517017

• Collection and analysis of biological samples from patients with multiple myeloma and related conditions

  This study is collecting and storing blood samples from patients with multiple myeloma and similar conditions to help researchers learn more about these diseases and improve treatments.

  Recruiting at 41 sites European Myeloma Network B.V. · Melbourne and 40 other locations · NCT06237803

• Evaluating a new CAR-NK cell treatment for relapsed multiple myeloma and plasma cell leukemia

  This study is testing a new CAR-NK cell treatment to see if it can help people with relapsed multiple myeloma or plasma cell leukemia feel better and improve their condition.

  Recruiting Early Phase 1 Hrain Biotechnology Co., Ltd. · Shanghai, Shanghai Municipality · NCT06045091

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.